InvestorsObserver is giving Kymera Therapeutics Inc (KYMR) an Analyst Rating Rank of 48, meaning KYMR is ranked higher by analysts than 48% of stocks. The average price target for KYMR is $48.461 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating KYMR a Strong Buy today. Find out what this means to you and get the rest of the rankings on KYMR!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Kymera Therapeutics Inc Stock Today?
Kymera Therapeutics Inc (KYMR) stock is trading at $39.90 as of 2:19 PM on Tuesday, Mar 19, an increase of $0.58, or 1.46% from the previous closing price of $39.32. Volume today is more active than usual. So far 1,163,358 shares have traded compared to average volume of 738,095 shares. The stock has traded between $38.78 and $40.30 so far today.
Click Here to get the full Stock Report for Kymera Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
